Saffron Formulations Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 24-10-2024
- Paid Up Capital ₹ 7.50 M
as on 24-10-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.95 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.01 Cr
as on 24-10-2024
- Revenue 29.52%
(FY 2023)
- Profit 532.31%
(FY 2023)
- Ebitda 17.10%
(FY 2023)
- Net Worth 16.91%
(FY 2023)
- Total Assets 32.68%
(FY 2023)
About Saffron Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹2.95 Cr. The company has closed loans amounting to ₹4.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Singh and Hiren Patel serve as directors at the Company.
- CIN/LLPIN
U74120GJ2015PTC083277
- Company No.
083277
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Saffron Formulations Private Limited offer?
Saffron Formulations Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Saffron Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Singh  | Director | 21-May-2015 | Current |
| Hiren Patel | Director | 21-May-2015 | Current |
Financial Performance of Saffron Formulations.
Saffron Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.52% increase. The company also saw a substantial improvement in profitability, with a 532.31% increase in profit. The company's net worth Soared by an impressive increase of 16.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saffron Formulations?
In 2023, Saffron Formulations had a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Nov 2022 | ₹5.00 M | Open |
Others Creation Date: 28 Jul 2022 | ₹2.45 Cr | Open |
Others Creation Date: 23 Sep 2020 | ₹1.96 Cr | Satisfied |
How Many Employees Work at Saffron Formulations?
Saffron Formulations has a workforce of 382 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saffron Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saffron Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
